Guardant Health Shares Move Lower On $350M Public Offering: The Details


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Guardant Health Inc (NASDAQ:GH) shares are trading lower Tuesday after the company announced an offering

What Happened: Guardant Health commenced an underwritten public offering of 12.5 million shares of its common stock at $28 per share. The company also granted the underwriters a 30-day option to purchase up to an additional 1.875 million shares. 

The offering is expected to close on or about May 25. Guardant Health anticipates $350 million in gross proceeds. 

Guardant Health is a precision oncology company focused on fighting cancer through proprietary tests, data sets and analytics. 

See Also: US Stocks Poised For Flat Open On Debt Ceiling Impasse: Why This Analyst Thinks October Lows 'Won't Be Violated'

GH Price Action: Guardant Health has a 52-week high of $62.55 and a 52-week low of $20.67. 

The stock was down 3.57% at $29.70 at the time of writing, per Benzinga Pro.

Photo: Tatiana from Pixabay.


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsOfferingsMoverswhy it's moving